Clinical Trials Browser

Has results × Prostatic Neoplasms × Erlotinib Hydrochloride × Clear all

NCT00996502 2019-03-27

Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate Cancer

Phase 1/2 Terminated

4 enrolled 2 charts

Prostatic Neoplasms

NCT00272038 2018-06-27

Single Agent Erlotinib in Chemotherapy-naive Androgen Independent Prostate Cancer

Phase 2 Completed

29 enrolled 8 charts

Prostatic Neoplasms

NCT00203424 2016-03-25

Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib

Phase 2 Completed

23 enrolled 9 charts

Prostatic Neoplasms